ID   ACO13_HUMAN             Reviewed;         140 AA.
AC   Q9NPJ3; F5H2L4; O95549;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   12-APR-2017, entry version 141.
DE   RecName: Full=Acyl-coenzyme A thioesterase 13;
DE            Short=Acyl-CoA thioesterase 13;
DE            EC=3.1.2.-;
DE   AltName: Full=Thioesterase superfamily member 2;
DE   Contains:
DE     RecName: Full=Acyl-coenzyme A thioesterase 13, N-terminally processed;
GN   Name=ACOT13; Synonyms=THEM2; ORFNames=HT012, PNAS-27;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adrenal gland, and Hypothalamus;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Promyelocytic leukemia;
RA   Yu W.-Q., Sun B.-Z., Chai Y.-B., Zhu F., Liu X.-S., Li Z., Lu F.,
RA   Yan W., Yang H., Zhao Z.-L.;
RT   "Human acute promyelocytic leukemia cell line NB4's apoptosis related
RT   genes.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS), FUNCTION, IDENTIFICATION BY
RP   MASS SPECTROMETRY, MUTAGENESIS OF ASP-65, AND SUBUNIT.
RX   PubMed=16934754; DOI=10.1016/j.bbrc.2006.08.025;
RA   Cheng Z., Song F., Shan X., Wei Z., Wang Y., Dunaway-Mariano D.,
RA   Gong W.;
RT   "Crystal structure of human thioesterase superfamily member 2.";
RL   Biochem. Biophys. Res. Commun. 349:172-177(2006).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOG, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF
RP   ASN-50; HIS-56; ASP-65 AND SER-83, AND SUBUNIT.
RX   PubMed=19170545; DOI=10.1021/bi801879z;
RA   Cao J., Xu H., Zhao H., Gong W., Dunaway-Mariano D.;
RT   "The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate
RT   recognition and catalysis illuminated by a structure and function
RT   based analysis.";
RL   Biochemistry 48:1293-1304(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of human thioesterase superfamily member 2.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Acyl-CoA thioesterases are a group of enzymes that
CC       catalyze the hydrolysis of acyl-CoAs to the free fatty acid and
CC       coenzyme A (CoASH), providing the potential to regulate
CC       intracellular levels of acyl-CoAs, free fatty acids and CoASH. Has
CC       acyl-CoA thioesterase activity towards medium (C12) and long-chain
CC       (C18) fatty acyl-CoA substrates. Can also hydrolyze 3-
CC       hydroxyphenylacetyl-CoA and 3,4-dihydroxyphenylacetyl-CoA (in
CC       vitro). May play a role in controlling adaptive thermogenesis (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:16934754,
CC       ECO:0000269|PubMed:19170545}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.9 uM for n-decanoyl-CoA {ECO:0000269|PubMed:19170545};
CC         KM=26 uM for n-octanoyl-CoA {ECO:0000269|PubMed:19170545};
CC         KM=5 uM for myristoyl-CoA {ECO:0000269|PubMed:19170545};
CC         KM=9 uM for palmitoyl-CoA {ECO:0000269|PubMed:19170545};
CC         KM=9 uM for oleoyl-CoA {ECO:0000269|PubMed:19170545};
CC         KM=10 uM for 3,4-dihydroxyphenylacetyl-CoA
CC         {ECO:0000269|PubMed:19170545};
CC         KM=40 uM for 3-hydroxyphenylacetyl-CoA
CC         {ECO:0000269|PubMed:19170545};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:16934754,
CC       ECO:0000269|PubMed:19170545}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q9CQR4}. Mitochondrion
CC       {ECO:0000250|UniProtKB:Q9CQR4}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9CQR4}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:Q9CQR4}. Note=During interphase, found both
CC       in the nucleus and in the cytoplasm. At mitosis, localizes to the
CC       spindle. Colocalizes with tubulin. {ECO:0000250|UniProtKB:Q9CQR4}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NPJ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NPJ3-2; Sequence=VSP_046101;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the thioesterase PaaI family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF155649; AAF67006.1; -; mRNA.
DR   EMBL; AF220186; AAF67651.1; -; mRNA.
DR   EMBL; AF274952; AAK07529.1; -; mRNA.
DR   EMBL; AK000508; BAA91215.1; -; mRNA.
DR   EMBL; AK309738; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL031775; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000894; AAH00894.1; -; mRNA.
DR   CCDS; CCDS4558.1; -. [Q9NPJ3-1]
DR   CCDS; CCDS54972.1; -. [Q9NPJ3-2]
DR   RefSeq; NP_001153566.1; NM_001160094.1. [Q9NPJ3-2]
DR   RefSeq; NP_060943.1; NM_018473.3. [Q9NPJ3-1]
DR   UniGene; Hs.731605; -.
DR   PDB; 2F0X; X-ray; 2.30 A; A/B/C/D/E/F/G/H=1-140.
DR   PDB; 2H4U; X-ray; 2.20 A; A/B/C/D=19-140.
DR   PDB; 3F5O; X-ray; 1.70 A; A/B/C/D/E/F/G/H=1-140.
DR   PDBsum; 2F0X; -.
DR   PDBsum; 2H4U; -.
DR   PDBsum; 3F5O; -.
DR   ProteinModelPortal; Q9NPJ3; -.
DR   SMR; Q9NPJ3; -.
DR   BioGrid; 120958; 24.
DR   IntAct; Q9NPJ3; 6.
DR   STRING; 9606.ENSP00000230048; -.
DR   DrugBank; DB08688; undecan-2-one.
DR   iPTMnet; Q9NPJ3; -.
DR   PhosphoSitePlus; Q9NPJ3; -.
DR   BioMuta; ACOT13; -.
DR   EPD; Q9NPJ3; -.
DR   MaxQB; Q9NPJ3; -.
DR   PaxDb; Q9NPJ3; -.
DR   PeptideAtlas; Q9NPJ3; -.
DR   PRIDE; Q9NPJ3; -.
DR   TopDownProteomics; Q9NPJ3-1; -. [Q9NPJ3-1]
DR   Ensembl; ENST00000230048; ENSP00000230048; ENSG00000112304. [Q9NPJ3-1]
DR   Ensembl; ENST00000537591; ENSP00000445552; ENSG00000112304. [Q9NPJ3-2]
DR   GeneID; 55856; -.
DR   KEGG; hsa:55856; -.
DR   UCSC; uc003nek.4; human. [Q9NPJ3-1]
DR   CTD; 55856; -.
DR   DisGeNET; 55856; -.
DR   GeneCards; ACOT13; -.
DR   H-InvDB; HIX0005627; -.
DR   HGNC; HGNC:20999; ACOT13.
DR   HPA; HPA019881; -.
DR   MIM; 615652; gene.
DR   neXtProt; NX_Q9NPJ3; -.
DR   OpenTargets; ENSG00000112304; -.
DR   PharmGKB; PA165617655; -.
DR   eggNOG; KOG3328; Eukaryota.
DR   eggNOG; COG2050; LUCA.
DR   GeneTree; ENSGT00390000013934; -.
DR   HOGENOM; HOG000170540; -.
DR   InParanoid; Q9NPJ3; -.
DR   KO; K17362; -.
DR   OMA; KVICEMK; -.
DR   OrthoDB; EOG091G125K; -.
DR   PhylomeDB; Q9NPJ3; -.
DR   TreeFam; TF315062; -.
DR   BRENDA; 3.1.2.20; 2681.
DR   Reactome; R-HSA-75105; Fatty Acyl-CoA Biosynthesis.
DR   SABIO-RK; Q9NPJ3; -.
DR   ChiTaRS; ACOT13; human.
DR   EvolutionaryTrace; Q9NPJ3; -.
DR   GenomeRNAi; 55856; -.
DR   PRO; PR:Q9NPJ3; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112304; -.
DR   CleanEx; HS_THEM2; -.
DR   Genevisible; Q9NPJ3; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0047617; F:acyl-CoA hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0051289; P:protein homotetramerization; IPI:UniProtKB.
DR   InterPro; IPR029069; HotDog_dom.
DR   InterPro; IPR003736; PAAI_dom.
DR   InterPro; IPR006683; Thioestr_dom.
DR   Pfam; PF03061; 4HBT; 1.
DR   SUPFAM; SSF54637; SSF54637; 1.
DR   TIGRFAMs; TIGR00369; unchar_dom_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Hydrolase; Mitochondrion; Nucleus;
KW   Reference proteome.
FT   CHAIN         1    140       Acyl-coenzyme A thioesterase 13.
FT                                /FTId=PRO_0000156697.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712}.
FT   CHAIN         2    140       Acyl-coenzyme A thioesterase 13, N-
FT                                terminally processed.
FT                                /FTId=PRO_0000424501.
FT   BINDING      50     50       Substrate.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES       2      2       N-acetylthreonine; in Acyl-coenzyme A
FT                                thioesterase 13, N-terminally processed.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES      27     27       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CQR4}.
FT   MOD_RES      37     37       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CQR4}.
FT   MOD_RES      43     43       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CQR4}.
FT   MOD_RES     108    108       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CQR4}.
FT   MOD_RES     127    127       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CQR4}.
FT   VAR_SEQ       1     26       MTSMTQSLREVIKAMTKARNFERVLG -> MVR (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046101.
FT   MUTAGEN      50     50       N->A: Reduced activity.
FT                                {ECO:0000269|PubMed:19170545}.
FT   MUTAGEN      56     56       H->A: Decreases affinity for substrate.
FT                                {ECO:0000269|PubMed:19170545}.
FT   MUTAGEN      65     65       D->A: Loss of activity.
FT                                {ECO:0000269|PubMed:16934754,
FT                                ECO:0000269|PubMed:19170545}.
FT   MUTAGEN      65     65       D->E,N: Reduced activity.
FT                                {ECO:0000269|PubMed:16934754,
FT                                ECO:0000269|PubMed:19170545}.
FT   MUTAGEN      83     83       S->A: Reduced activity.
FT                                {ECO:0000269|PubMed:19170545}.
FT   HELIX         3     15       {ECO:0000244|PDB:3F5O}.
FT   STRAND       18     20       {ECO:0000244|PDB:3F5O}.
FT   HELIX        21     25       {ECO:0000244|PDB:3F5O}.
FT   STRAND       29     34       {ECO:0000244|PDB:3F5O}.
FT   STRAND       37     43       {ECO:0000244|PDB:3F5O}.
FT   HELIX        46     48       {ECO:0000244|PDB:3F5O}.
FT   STRAND       53     55       {ECO:0000244|PDB:3F5O}.
FT   HELIX        57     73       {ECO:0000244|PDB:3F5O}.
FT   STRAND       75     77       {ECO:0000244|PDB:3F5O}.
FT   STRAND       82     90       {ECO:0000244|PDB:3F5O}.
FT   STRAND       99    109       {ECO:0000244|PDB:3F5O}.
FT   STRAND      111    122       {ECO:0000244|PDB:3F5O}.
FT   TURN        123    125       {ECO:0000244|PDB:3F5O}.
FT   STRAND      128    137       {ECO:0000244|PDB:3F5O}.
SQ   SEQUENCE   140 AA;  14960 MW;  084E36EFEE715A18 CRC64;
     MTSMTQSLRE VIKAMTKARN FERVLGKITL VSAAPGKVIC EMKVEEEHTN AIGTLHGGLT
     ATLVDNISTM ALLCTERGAP GVSVDMNITY MSPAKLGEDI VITAHVLKQG KTLAFTSVDL
     TNKATGKLIA QGRHTKHLGN
//
